Skip to main content
OpenTrials
Completed

NCT Number: NCT00644098

Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors

The purpose of this study is to investigate whether the addition of capsules containing soluble fibre complex emulsified with medium chain triglycerides and taken before with meals will lead to a significant amount of weight loss, reduced glycemic volatility and diminished cardio metabolic risk factors in overweight and obese individuals when compared to a placebo control.

We believe that those participants taking 3-6 capsules per day of the treatment capsules over a 14 week period will loose a significant amount of weight compared to the placebo group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

People Who Are Overweight or Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

20 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Canadian Center for Functional Medicine

Coquitlam, British Columbia, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI 27 - 35 kg/m2

Exclusion criteria

-

Treatment and study plan

soluble fibre complex and medium chain triglycerides

Dietary Supplement

cellulose and soybean oil

Dietary Supplement

Primary outcomes

  1. weight loss

    Time frame: baseline, biweekly and final visit

Secondary outcomes

  1. glycemic volatility and cardio metabolic risk factors

    Time frame: baseline and final visit

Sponsors and collaborators

Lead sponsor

Canadian Center for Functional Medicine

Other

Collaborators

  • University of British Columbia

Registry information

Official study title

The Effect and Dose-response of Soluble Fibre Blend and Medium Chain Triglycerides (MCT) on Body Composition and Cardiometabolic Risk Factors in Overweight and Obese Adults: a Double-blind, Placebo-controlled Study.

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Mar 26, 2008
Registry last updated
Oct 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.